Development of antibodies against the notch ligand Delta-Like-1 by phage display with activity against breast cancer cells
- 1 September 2021
- journal article
- research article
- Published by Elsevier in New Biotechnology
- Vol. 64, 17-26
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Assessment of potential anti-cancer stem cell activity of marine algal compounds using an in vitro mammosphere assayCancer Cell International, 2013
- Specific inhibition of Notch1 signaling enhances the antitumor efficacy of chemotherapy in triple negative breast cancer through reduction of cancer stem cellsCancer Letters, 2013
- Stabilisation of the Fc Fragment of Human IgG1 by Engineered Intradomain Disulfide BondsPLOS ONE, 2012
- Maintenance of hormone responsiveness in luminal breast cancers by suppression of NotchProceedings of the National Academy of Sciences, 2011
- Hypoxia-induced Jagged2 promotes breast cancer metastasis and self-renewal of cancer stem-like cellsOncogene, 2011
- Tumor-Derived Jagged1 Promotes Osteolytic Bone Metastasis of Breast Cancer by Engaging Notch Signaling in Bone CellsCancer Cell, 2011
- Precise determination of the diversity of a combinatorial antibody library gives insight into the human immunoglobulin repertoireProceedings of the National Academy of Sciences, 2009
- The Canonical Notch Signaling Pathway: Unfolding the Activation MechanismCell, 2009
- A conserved face of the Jagged/Serrate DSL domain is involved in Notch trans-activation and cis-inhibitionNature Structural & Molecular Biology, 2008
- High-level Coexpression of JAG1 and NOTCH1 Is Observed in Human Breast Cancer and Is Associated with Poor Overall SurvivalCancer Research, 2005